Crescita Therapeutics Inc. (TSX:CTX)

Crescita Therapeutics Statistics

Total Valuation

TSX:CTX has a market cap or net worth of CAD 14.15 million. The enterprise value is 7.94 million.

Market Cap	14.15M
Enterprise Value	7.94M

Important Dates

The next estimated earnings date is Friday, May 22, 2026.

Earnings Date	May 22, 2026
Ex-Dividend Date	n/a

Share Statistics

TSX:CTX has 18.61 million shares outstanding. The number of shares has decreased by -2.43% in one year.

Current Share Class	18.61M
Shares Outstanding	18.61M
Shares Change (YoY)	-2.43%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	13.48%
Owned by Institutions (%)	n/a
Float	16.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.61
PB Ratio	0.98
P/TBV Ratio	1.08
P/FCF Ratio	21.18
P/OCF Ratio	8.19
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.42, with an EV/FCF ratio of 11.88.

EV / Earnings	-24.80
EV / Sales	0.34
EV / EBITDA	22.42
EV / EBIT	n/a
EV / FCF	11.88

Financial Position

The company has a current ratio of 2.80, with a Debt / Equity ratio of 0.17.

Current Ratio	2.80
Quick Ratio	2.00
Debt / Equity	0.17
Debt / EBITDA	6.76
Debt / FCF	3.74
Interest Coverage	-19.42

Financial Efficiency

Return on equity (ROE) is -2.19% and return on invested capital (ROIC) is -14.99%.

Return on Equity (ROE)	-2.19%
Return on Assets (ROA)	-3.31%
Return on Invested Capital (ROIC)	-14.99%
Return on Capital Employed (ROCE)	-7.04%
Weighted Average Cost of Capital (WACC)	3.22%
Revenue Per Employee	357,200
Profits Per Employee	-4,923
Employee Count	65
Asset Turnover	1.06
Inventory Turnover	2.38

Taxes

In the past 12 months, TSX:CTX has paid 9,000 in taxes.

Income Tax	9,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +42.59% in the last 52 weeks. The beta is -0.15, so TSX:CTX's price volatility has been lower than the market average.

Beta (5Y)	-0.15
52-Week Price Change	+42.59%
50-Day Moving Average	0.68
200-Day Moving Average	0.54
Relative Strength Index (RSI)	81.52
Average Volume (20 Days)	16,645

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:CTX had revenue of CAD 23.22 million and -320,000 in losses. Loss per share was -0.02.

Revenue	23.22M
Gross Profit	12.18M
Operating Income	-1.17M
Pretax Income	-311,000
Net Income	-320,000
EBITDA	-65,000
EBIT	-1.17M
Loss Per Share	-0.02

Balance Sheet

The company has 8.71 million in cash and 2.50 million in debt, with a net cash position of 6.21 million or 0.33 per share.

Cash & Cash Equivalents	8.71M
Total Debt	2.50M
Net Cash	6.21M
Net Cash Per Share	0.33
Equity (Book Value)	14.42M
Book Value Per Share	0.77
Working Capital	10.17M

Cash Flow

In the last 12 months, operating cash flow was 1.73 million and capital expenditures -1.06 million, giving a free cash flow of 668,000.

Operating Cash Flow	1.73M
Capital Expenditures	-1.06M
Depreciation & Amortization	1.10M
Net Borrowing	-457,000
Free Cash Flow	668,000
FCF Per Share	0.04

Margins

Gross margin is 52.47%, with operating and profit margins of -5.02% and -1.38%.

Gross Margin	52.47%
Operating Margin	-5.02%
Pretax Margin	-1.34%
Profit Margin	-1.38%
EBITDA Margin	-0.28%
EBIT Margin	-5.02%
FCF Margin	2.88%

Dividends & Yields

TSX:CTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.43%
Shareholder Yield	2.43%
Earnings Yield	-2.26%
FCF Yield	4.72%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSX:CTX has an Altman Z-Score of -0.79 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.79
Piotroski F-Score	5